Old Web
English
Sign In
Acemap
>
authorDetail
>
Helene Bichat
Helene Bichat
University Hospital of Lausanne
Melanoma
Immunology
Medicine
Immunotherapy
Cancer
3
Papers
59
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Effect of Melan-Α/Μart-1-peptide vaccination plus IMP321 on antitumor immunity and clinical benefit in patients receiving autologous PBMCs after lymphodepletion.
2017
Journal of Clinical Oncology
Emanuela Romano
Helene Bichat
Athina Stravodimou
Pedro Romero
Speiser E Daniel
Frédéric Triebel
Olivier Michielin
Alexander Harari
Serge Leyvraz
Show All
Source
Cite
Save
Citations (0)
MART-1 peptide vaccination plus IMP321 (LAG-3Ig fusion protein) in patients receiving autologous PBMCs after lymphodepletion: results of a Phase I trial
2014
Journal of Translational Medicine
Emanuela Romano
Olivier Michielin
Verena Voelter
Julien Laurent
Helene Bichat
Athina Stravodimou
Pedro Romero
Daniel E. Speiser
Frédéric Triebel
Serge Leyvraz
Alexandre Harari
Show All
Source
Cite
Save
Citations (55)
FcgRIIIA (CD16)-expressing monocytes mediate the depletion of tumor-infiltrating Tregs via Ipilimumab-dependent ADCC in melanoma patients
2014
Journal for ImmunoTherapy of Cancer
Emanuela Romano
Monika Kusio-Kobialka
Periklis G. Foukas
Helene Bichat
Petra Baumgaertner
Christiane Meyer
Pierluigi Ballabeni
Olivier Michielin
Benjamin Weide
Pedro Romero
Daniel E. Speiser
Show All
Source
Cite
Save
Citations (4)
1